Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 2
1971 6
1972 8
1973 16
1974 8
1975 9
1976 23
1977 27
1978 24
1979 16
1980 33
1981 32
1982 32
1983 31
1984 28
1985 30
1986 35
1987 25
1988 35
1989 34
1990 32
1991 28
1992 37
1993 35
1994 31
1995 23
1996 22
1997 18
1998 26
1999 23
2000 20
2001 22
2002 14
2003 14
2004 14
2005 14
2006 22
2007 18
2008 17
2009 13
2010 9
2011 2
2012 15
2013 12
2014 10
2015 6
2016 5
2017 7
2018 11
2019 9
2020 8
2021 6
2022 1
2023 2
2024 2
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

975 results

Results by year

Filters applied: . Clear all
Page 1
Nifedipine versus terbutaline, tocolytic effectiveness and maternal and neonatal adverse effects: a randomized, controlled pilot trial.
Padovani TR, Guyatt G, Lopes LC. Padovani TR, et al. Basic Clin Pharmacol Toxicol. 2015 Mar;116(3):244-50. doi: 10.1111/bcpt.12306. Epub 2014 Sep 19. Basic Clin Pharmacol Toxicol. 2015. PMID: 25146233 Clinical Trial.
Although previous evidence suggests advantages of nifedipine over terbutaline as tocolytic agents, in some jurisdictions, terbutaline is approved for use and nifedipine is not. ...The total number of side effects, and the proportion of women experiencing one or more …
Although previous evidence suggests advantages of nifedipine over terbutaline as tocolytic agents, in some jurisdictions, terbutal …
Fenoterol in asthma.
Anderson G, Wilkins E, Jariwalla AG. Anderson G, et al. Br J Dis Chest. 1979 Jan;73(1):81-4. Br J Dis Chest. 1979. PMID: 373786 Clinical Trial.
In a double-blind cross-over trial in 17 asthmatic patients with reversible airway obstruction inhalation of both fenoterol (0.4 mg) and terbutaline (0.5 mg) produced a statistically significant greater increase in peak expiratory flow rate than did placebo. The magnitude …
In a double-blind cross-over trial in 17 asthmatic patients with reversible airway obstruction inhalation of both fenoterol (0.4 mg) and …
Nebulized Terbutaline and Ipratropium Bromide Versus Terbutaline Alone in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Requiring Noninvasive Ventilation: A Randomized Double-blind Controlled Trial.
Beltaief K, Msolli MA, Zorgati A, Sekma A, Fakhfakh M, Marzouk MB, Boubaker H, Grissa MH, Methamem M, Boukef R, Belguith A, Bouida W, Nouira S. Beltaief K, et al. Acad Emerg Med. 2019 Apr;26(4):434-442. doi: 10.1111/acem.13560. Epub 2018 Oct 21. Acad Emerg Med. 2019. PMID: 30156361 Free article. Clinical Trial.
METHODS: In this double-blind controlled trial, patients who were admitted to the ED for AECOPD requiring noninvasive ventilation (NIV) were randomized to receive either 5 mg of nebulized terbutaline combined to 0.5 mg of IB (terbutaline/IB group, n = 115) or 5 mg o …
METHODS: In this double-blind controlled trial, patients who were admitted to the ED for AECOPD requiring noninvasive ventilation (NIV) were …
Terbutaline and diaphragm function in chronic obstructive pulmonary disease: a double-blind randomized clinical trial.
Stoller JK, Wiedemann HP, Loke J, Snyder P, Virgulto J, Matthay RA. Stoller JK, et al. Br J Dis Chest. 1988 Jul;82(3):242-50. doi: 10.1016/0007-0971(88)90064-2. Br J Dis Chest. 1988. PMID: 3073804 Clinical Trial.
We conducted a double-blind, randomized crossover trial to evaluate whether oral terbutaline (2.5 mg orally three times daily for a week) increased the force of diaphragmatic contraction in normocapnic patients with chronic obstructive pulmonary disease. ...These small cha …
We conducted a double-blind, randomized crossover trial to evaluate whether oral terbutaline (2.5 mg orally three times daily for a w …
Terbutaline versus salbutamol for suppression of preterm labor: a randomized clinical trial.
Motazedian S, Ghaffarpasand F, Mojtahedi K, Asadi N. Motazedian S, et al. Ann Saudi Med. 2010 Sep-Oct;30(5):370-5. doi: 10.4103/0256-4947.67079. Ann Saudi Med. 2010. PMID: 20697169 Free PMC article. Clinical Trial.
PATIENTS AND METHODS: Two hundred women with PTL were randomly assigned to receive subcutaneous terbutaline (250 mug) or intravenous salbutamol (0.1 mg) followed by oral terbutaline (20 mg/d) or oral salbutamol (24 mg/d) as maintenance. ...However, terbutaline …
PATIENTS AND METHODS: Two hundred women with PTL were randomly assigned to receive subcutaneous terbutaline (250 mug) or intravenous …
A comparison of the clinical efficacy and patient acceptability of terbutaline Turbuhaler and salbutamol Rotahaler, in adult patients with asthma.
Gioulekas D, Papakosta D, Vordoyianni P, Baloti H, Vamvalis C. Gioulekas D, et al. Respir Med. 1996 Apr;90(4):205-9. doi: 10.1016/s0954-6111(96)90288-7. Respir Med. 1996. PMID: 8736653 Free article. Clinical Trial.
Thirty-two adult asthmatics (21 males and 11 females with a mean age of 34 years) who demonstrated at least 15% reversibility in PEF or FEV1 in response to terbutaline, were enrolled for study. The median reversibility in FEV1 was 27.5% for the terbutaline-salbutamo …
Thirty-two adult asthmatics (21 males and 11 females with a mean age of 34 years) who demonstrated at least 15% reversibility in PEF or FEV1 …
Randomized trial of oral indomethacin and terbutaline sulfate for the long-term suppression of preterm labor.
Bivins HA Jr, Newman RB, Fyfe DA, Campbell BA, Stramm SL. Bivins HA Jr, et al. Am J Obstet Gynecol. 1993 Oct;169(4):1065-70. doi: 10.1016/0002-9378(93)90055-n. Am J Obstet Gynecol. 1993. PMID: 8238121 Clinical Trial.
OBJECTIVE: Our purpose was to determine the efficacy and safety of long-term oral tocolysis with indomethacin or terbutaline sulfate. STUDY DESIGN: Seventy-one patients at 26 to 32 weeks' gestation admitted for preterm labor were prospectively randomized to receive oral in …
OBJECTIVE: Our purpose was to determine the efficacy and safety of long-term oral tocolysis with indomethacin or terbutaline sulfate. …
Comparison of nebulized epinephrine and terbutaline in patients with acute severe asthma: a controlled trial.
Adoun M, Frat JP, Doré P, Rouffineau J, Godet C, Robert R. Adoun M, et al. J Crit Care. 2004 Jun;19(2):99-102. doi: 10.1016/j.jcrc.2004.04.005. J Crit Care. 2004. PMID: 15236142 Clinical Trial.
The improvement in PaO2 was only significant with terbutaline. Respiratory frequency, PEF and PaO2 were not improved by the second nebulization. ...CONCLUSIONS: Adrenaline nebulization was as effective and as well tolerated as terbutaline in acute severe asthma. No …
The improvement in PaO2 was only significant with terbutaline. Respiratory frequency, PEF and PaO2 were not improved by the second ne …
The effect of tocolytic agents (indomethacin and terbutaline) on fetal breathing and body movements: a prospective, randomized, double-blind, placebo-controlled clinical trial.
Hallak M, Moise K Jr, Lira N, Dorman KF, Smith EO, Cotton DB. Hallak M, et al. Am J Obstet Gynecol. 1992 Oct;167(4 Pt 1):1059-63. doi: 10.1016/s0002-9378(12)80038-x. Am J Obstet Gynecol. 1992. PMID: 1415392 Clinical Trial.
OBJECTIVE: The null hypothesis of this study is that maternal administration of indomethacin or terbutaline will not affect fetal breathing and body movements. STUDY DESIGN: Thirty patients with a low-risk pregnancy, gestational age 26 to 32 weeks, and no signs of preterm …
OBJECTIVE: The null hypothesis of this study is that maternal administration of indomethacin or terbutaline will not affect fetal bre …
975 results